0000930413-20-000575.txt : 20200226 0000930413-20-000575.hdr.sgml : 20200226 20200226171800 ACCESSION NUMBER: 0000930413-20-000575 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200224 FILED AS OF DATE: 20200226 DATE AS OF CHANGE: 20200226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RABBANI ELAZAR CENTRAL INDEX KEY: 0000903568 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 20657134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 0731 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 ownership.xml X0306 4 2020-02-24 0 0000316253 ENZO BIOCHEM INC ENZ 0000903568 RABBANI ELAZAR C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 0 1 0 0 CHIEF EXECUTIVE OFFICER Stock Option (to acquire Common Stock) 2.20 2020-02-24 4 A 0 130100 0 A 2021-02-24 2031-02-24 Common Stock 130100 310715 D The Reporting Person was granted 130,100 stock options. The stock options have a ten-year term and will vest in two equal installments, one on the first anniversary of the grant date and the other on the second anniversary of the grant date. Does not include 26,900 Performance Stock Units granted to the Reporting Person on February 24, 2020, which will vest, if at all, based on (i) the achievement of certain average revenue growth and average adjusted EBITDA growth goals on February 24, 2023 and (ii) the continued employment of the Reporting Person through February 24, 2023. /s/ Elazar Rabbani 2020-02-26